Robert G. L. Shorr
Founder at Cornerstone Pharmaceuticals, Inc.
Robert G. L. Shorr active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| Founder | - | - | |
| Chief Executive Officer | 1999-12-31 | 2014-10-09 | |
| Stony Brook University | Corporate Officer/Principal | 1997-12-31 | - |
| Tissue Engineering Charities, Inc. | Director/Board Member | 2011-05-15 | - |
| Imperial College London | Director/Board Member | 1998-12-31 | - |
Career history of Robert G. L. Shorr
Former positions of Robert G. L. Shorr
| Companies | Position | Start | End |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 2005-03-30 | 2018-01-31 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director/Board Member | - | 2005-04-27 |
| UNITED THERAPEUTICS CORPORATION | Chief Tech/Sci/R&D Officer | 2004-12-31 | 2004-12-31 |
| Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 1987-12-31 | 1987-12-31 |
| AT Biochem, Inc. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | 2010-05-06 | - | |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Training of Robert G. L. Shorr
| University of London | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Statistics
International
| United States | 10 |
| United Kingdom | 4 |
Operational
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private companies | 5 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
| AT Biochem, Inc. | |
| Tissue Engineering Charities, Inc. | |
| Smithkline & French Laboratories US, Inc. |
- Stock Market
- Insiders
- Robert G. L. Shorr
- Experience
